ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Jong, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Jong, J. W.

Ann Thorac Surg 1986;42:593-598
© 1986 The Society of Thoracic Surgeons


Articles

Cardioplegia and Calcium Antagonists: A Review

Jan W. de Jong, Ph.D.*

From the Cardiochemical Laboratory, Thoraxcenter, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands

* Address reprint requests to Dr. de Jong

During open-heart operations, periods occur during which the blood supply to the heart is stopped. Myocardial damage can be limited by cooling and induction of electromechanical arrest (cardioplegia). Many animal studies and some clinical trials provide strong evidence for the use of calcium antagonists, such as nifedipine, verapamil hydrochloride, diltiazem hydrochloride, and lidoflazine, as adjuncts to cardioplegia to optimize the protection. Salutary effects of calcium antagonists are discussed in regard to possible mechanism of action, application time, and efficacy during hypothermia. A major conclusion is that virtually no negative effects on cardiac protection have as yet been described in experimental or clinical studies, apart from short-term negative inotropic responses, while there is an increasing body of positive evidence for their efficacy. A new development is the use of these drugs for regional cardioplegia during dilation of coronary arteries (transluminal angioplasty).




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. S. Brown, G. L. Parenteau, F. W. Holland, and R. E. Clark
Pretreatment with nicardipine preserves ventricular function after hypothermic ischemic arrest
Ann. Thorac. Surg., May 1, 1991; 51(5): 739 - 746.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Hochhauser, Y. Barak, S. Einav, S. Cohen, and B. Vidne
Effect of Experimental Cardioplegia Methods on Normal and Hypertrophied Rat Hearts
Ann. Thorac. Surg., August 1, 1988; 46(2): 208 - 213.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The Society of Thoracic Surgeons.